Clinical effectiveness and safety of sanchi tong shu capsule in the treatment of aural vertigo: a multi-center randomized controlled clinical trial / 临床耳鼻咽喉头颈外科杂志
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
; (24): 295-299, 2012.
Article
en Zh
| WPRIM
| ID: wpr-749412
Biblioteca responsable:
WPRO
ABSTRACT
OBJECTIVE@#To evaluate the clinical effectiveness and safety of Sanchi Tong Shu capsule in the treatment of common aural vertigo.@*METHOD@#A multi-center randomized controlled trial was designed to study 206 vertigo patients who were randomly allocated into one of the two groups. One group was treated with Sanchi Tong Shu capsule for 14 days, another group was treated with betahistine mesilate tablets for 14 days.@*RESULT@#The clinical effectiveness rates of the two groups were 84.86% and 90.92% respectively according to FAS analysis and 84.76%, 90.92% respectively according to PPS analysis. No statistic significance difference was found between the two groups (P > 0.05). After 14 days treatment, total DHI and all the subsection (including body, emotion and function) scores of the two groups were all decreased compared with treatment before (P 0.05). The adverse effective rate of the two groups were 3.29% and 7.84% respectively and there was no statistic difference between the two groups (P > 0.05).@*CONCLUSION@#Sanchi Tong Shu capsule is a safe and effective drug for the treatment of common aural vertigo.
Texto completo:
1
Base de datos:
WPRIM
Asunto principal:
Betahistina
/
Medicamentos Herbarios Chinos
/
Resultado del Tratamiento
/
Usos Terapéuticos
/
Quimioterapia
/
Fitoterapia
/
Enfermedad de Meniere
Tipo de estudio:
Clinical_trials
Límite:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
Idioma:
Zh
Revista:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
Año:
2012
Tipo del documento:
Article